Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-21 Sale | 2025-05-23 4:06 pm | ACELYRIN Inc. | SLRN | Svoronos Dawn Director | 15,000 | $0 | $0 | 0 (Direct) | View |
| 2023-08-24 Sale | 2023-08-24 4:33 pm | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 25,000 | $38.7 | $967,500 | 25,000 (Direct) | View |
| 2023-05-09 Purchase | 2023-05-11 9:11 pm | ACELYRIN Inc. | SLRN | Svoronos Dawn Director | 15,000 | $18 | $270,000 | 193,693 (Direct) | View |
| 2022-10-05 Sale | 2022-10-06 4:20 pm | Global Blood Therapeutics Inc. | GBT | Svoronos Dawn Director | 5,376 | $0 | $0 | 0 (Direct) | View |
| 2022-06-21 Sale | 2022-06-22 6:00 pm | Global Blood Therapeutics Inc. | GBT | Svoronos Dawn Director | 1,908 | $27.24 | $51,983 | 5,376 (Direct) | View |
| 2022-06-09 Sale | 2022-06-10 4:06 pm | PTC THERAPEUTICS INC. | PTCT | Svoronos Dawn Director | 738 | $27.2 | $20,074 | 29,017 (Direct) | View |
| 2022-05-16 Purchase | 2022-05-18 4:43 pm | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 30,000 | $0.8526 | $25,578 | 50,000 (Direct) | View |
| 2022-01-07 Sale | 2022-01-11 4:14 pm | PTC THERAPEUTICS INC. | PTCT | Svoronos Dawn Director | 510 | $38.52 | $19,648 | 41,755 (Direct) | View |
| 2021-06-18 Sale | 2021-06-21 4:31 pm | Global Blood Therapeutics Inc. | GBT | Svoronos Dawn Director | 1,609 | $36.54 | $58,793 | 12,884 (Direct) | View |
| 2021-06-09 Sale | 2021-06-11 4:47 pm | PTC THERAPEUTICS INC. | PTCT | Svoronos Dawn Director | 365 | $41.88 | $15,288 | 27,065 (Direct) | View |
| 2021-03-31 Purchase | 2021-04-01 8:21 pm | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 20,000 | $10.02 | $200,338 | 20,000 (Direct) | View |
| 2021-02-01 Sale | 2021-02-02 6:18 pm | PTC THERAPEUTICS INC. | PTCT | Svoronos Dawn Director | 506 | $56.96 | $28,820 | 27,430 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-09 Equity Swap | 2025-12-10 1:31 pm | N/A N/A | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 5,000 | $0 | 0 (Direct) | View |
| 2025-06-17 Option Award | 2025-06-20 4:24 pm | N/A 2035-06-16 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 10,450 | $0 | 10,450 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-06 5:57 pm | N/A 2035-06-04 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 19,657 | $0 | 19,657 (Direct) | View |
| 2024-06-17 Option Award | 2024-06-20 4:47 pm | N/A 2034-06-16 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 10,520 | $0 | 10,520 (Direct) | View |
| 2024-06-07 Option Award | 2024-06-11 7:07 pm | N/A 2034-06-06 | ACELYRIN Inc. | SLRN | Svoronos Dawn Director | 92,158 | $0 | 92,158 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-05 5:41 pm | N/A 2034-06-04 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 15,542 | $0 | 15,542 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-13 5:10 pm | N/A 2033-06-08 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-02 5:24 pm | N/A 2033-06-01 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 18,475 | $0 | 18,475 (Direct) | View |
| 2023-05-09 Other | 2023-05-11 9:11 pm | N/A 2032-11-30 | ACELYRIN Inc. | SLRN | Svoronos Dawn Director | 357,386 | $0 | 193,693 (Direct) | View |
| 2023-05-04 Option Award | 2023-05-04 8:24 pm | N/A 2033-05-03 | ACELYRIN Inc. | SLRN | Svoronos Dawn Director | 23,243 | $0 | 23,243 (Direct) | View |
Ownership | 2023-05-04 7:49 pm | N/A 2032-11-30 | ACELYRIN Inc. | SLRN | Svoronos Dawn Director | 0 | $0 | 155,450 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-29 5:44 pm | N/A 2032-06-27 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2022-06-14 Option Award | 2022-06-16 6:00 pm | N/A 2032-06-13 | Global Blood Therapeutics Inc. | GBT | Svoronos Dawn Director | 9,200 | $0 | 16,484 (Direct) | View |
| 2022-06-14 Exercise | 2022-06-16 6:00 pm | 2022-06-14 N/A | Global Blood Therapeutics Inc. | GBT | Svoronos Dawn Director | 3,600 | $0 | 16,484 (Direct) | View |
| 2022-06-10 Option Award | 2022-06-14 4:22 pm | N/A 2032-06-09 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-11 4:14 pm | N/A 2032-01-06 | PTC THERAPEUTICS INC. | PTCT | Svoronos Dawn Director | 15,200 | $0 | 41,755 (Direct) | View |
| 2021-06-17 Option Award | 2021-06-21 4:31 pm | N/A 2031-06-16 | Global Blood Therapeutics Inc. | GBT | Svoronos Dawn Director | 9,200 | $0 | 12,884 (Direct) | View |
| 2021-06-17 Exercise | 2021-06-21 4:31 pm | 2021-06-17 N/A | Global Blood Therapeutics Inc. | GBT | Svoronos Dawn Director | 3,037 | $0 | 12,884 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 9:16 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | Svoronos Dawn Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2021-05-12 Option Award | 2021-05-14 8:04 pm | N/A 2031-05-11 | Adverum Biotechnologies Inc. | ADVM | Svoronos Dawn Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-01-06 Option Award | 2021-01-08 5:09 pm | N/A 2031-01-05 | PTC THERAPEUTICS INC. | PTCT | Svoronos Dawn Director | 11,650 | $0 | 37,936 (Direct) | View |